Hereditary Tyrosinemia Compounded With Hyperinsulinemic Hypoglycemia: Challenging Diagnosis of a Rare Case.

作者: Sharmeen Nasir , Mohammad Raza , Samrah I Siddiqui , Ayesha Saleem , Awais Abbas

DOI: 10.7759/CUREUS.11541

关键词:

摘要: Abstract Hereditary tyrosinemia type 1 (HT-1) is a rare autosomal recessive disorder caused by a deficiency in the enzyme fumarylacetoacetate hydrolase (FAH), which catalyzes the final step in the tyrosine degradation pathway. Hereditary tyrosinemia is a heterogeneous disease with a wide spectrum of clinical manifestations involving hepatic, renal, or nervous systems. It has grave consequences if left untreated. Some of the late complications of hereditary tyrosinemia include cirrhosis, liver nodules, hepatocellular carcinoma …

参考文章(11)
Mohammad Hadi Imanieh, Abdorrasoul Malekpour, Mahmood Haghighat, Seyed Mohsen Dehghani, Hossein Karamnejad, Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation International Journal of Preventive Medicine. ,vol. 4, pp. 1380- 1385 ,(2013)
Pierre A. Russo, Grant A. Mitchell, Robert M. Tanguay, Tyrosinemia: A Review Pediatric and Developmental Pathology. ,vol. 4, pp. 212- 221 ,(2001) , 10.1007/S100240010146
Saskia M M Jacobs, Denis H A van Beurden, Leo W J Klomp, Ruud Berger, Inge E T van den Berg, Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity. Pediatric Research. ,vol. 59, pp. 365- 370 ,(2006) , 10.1203/01.PDR.0000198810.57642.B4
Elisabeth Holme, Sven Lindstedt, Nontransplant treatment of tyrosinemia. Clinics in Liver Disease. ,vol. 4, pp. 805- 814 ,(2000) , 10.1016/S1089-3261(05)70142-2
U. Baumann, M. A. Preece, A. Green, D. A. Kelly, P. J. McKiernan, Hyperinsulinism in tyrosinaemia type I. Journal of Inherited Metabolic Disease. ,vol. 28, pp. 131- 135 ,(2005) , 10.1007/S10545-005-5517-1
Corinne de Laet, Carlo Dionisi-Vici, James V Leonard, Patrick McKiernan, Grant Mitchell, Lidia Monti, Hélène Ogier de Baulny, Guillem Pintos-Morell, Ute Spiekerkötter, Recommendations for the management of tyrosinaemia type 1 Orphanet Journal of Rare Diseases. ,vol. 8, pp. 8- 8 ,(2013) , 10.1186/1750-1172-8-8
C. Ronald Scott, The genetic tyrosinemias American Journal of Medical Genetics Part C: Seminars in Medical Genetics. ,vol. 142C, pp. 121- 126 ,(2006) , 10.1002/AJMG.C.30092
Julia Geppert, Chris Stinton, Karoline Freeman, Hannah Fraser, Aileen Clarke, Samantha Johnson, Paul Sutcliffe, Sian Taylor-Phillips, Evaluation of pre-symptomatic nitisinone treatment on long-term outcomes in Tyrosinemia type 1 patients: a systematic review Orphanet Journal of Rare Diseases. ,vol. 12, pp. 154- 154 ,(2017) , 10.1186/S13023-017-0696-Z
Hüseyin Demirbilek, Khalid Hussain, Congenital Hyperinsulinism: Diagnosis and Treatment Update. Journal of Clinical Research in Pediatric Endocrinology. ,vol. 9, pp. 69- 87 ,(2018) , 10.4274/JCRPE.2017.S007